Drugs / Enhanced ALPP CAR-T
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07487597 | Feb 2026 → Feb 2028 expected | cancer | TCRCure Biopharma Ltd. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enhanced ALPP CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07487597 ↗ |
| Modality | Cell therapy | “ALPP CAR-T cell infusion” NCT07487597 ↗ |
| Target | ALPP | “ALPP-targeted” NCT07487597 ↗ |